Brief: Karyopharm Therapeutics Provides Endometrial Cancer Program Update

Karyopharm Therapeutics

03/12/2024 12:04

Dec 3 (Reuters) - Karyopharm Therapeutics  KPTI.O :
    * KARYOPHARM THERAPEUTICS PROVIDES ENDOMETRIAL CANCER
PROGRAM
UPDATE
    * KARYOPHARM: HAS UPCOMING MEETING WITH U.S. FDA REGARDING
TREATMENT LANDSCAPE IN ENDOMETRIAL CANCER, IMPLICATIONS ON PHASE
3 XPORT-EC-042 TRIAL
    * KARYOPHARM: INTENDS TO PROVIDE AN UPDATE ON ITS
ENDOMETRIAL
CANCER PROGRAM AS SOON AS PRACTICAL FOLLOWING DISCUSSION WITH
FDA

Source text:  ID:nPnN8Tmba 
Further company coverage:  KPTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))